# FDA recall D-0033-2026

> **JB Chemicals and Pharmaceuticals Ltd** · Class III · drug recall initiated 2025-09-12.

## Product

Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50

## Reason for recall

Tablet/Capsules Imprinted with Wrong ID

## Distribution

U.S. Nationwide

## Key facts

- **Recall number:** D-0033-2026
- **Recalling firm:** JB Chemicals and Pharmaceuticals Ltd
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-09-12
- **Report date:** 2025-10-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mumbai, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0033-2026

## Citation

> AI Analytics. FDA recall D-0033-2026. Retrieved 2026-07-01 from https://api.ai-analytics.org/recall/D-0033-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*